Board Meeting Details
The Board of Directors meeting was held on July 29, 2026, commencing at 12:30 PM and concluding at 2:15 PM.
Key Decisions Approved
1. Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with Limited Review Reports from Statutory Auditors
2. Declaration of Interim Dividend of 450% (₹4.50 per equity share of ₹1 each) for FY2026-27
3. Fixation of Record Date for dividend payment as Tuesday, August 4, 2026
Standalone Financial Results (₹ in Crores)
Income Statement Highlights:
- Revenue from Operations: Q1 FY27 ₹1,653.48 (Q4 FY26: ₹1,371.07, Q1 FY26: ₹1,452.98)
- Other Income: Q1 FY27 ₹4.18 (Q4 FY26: ₹6.87, Q1 FY26: ₹7.34)
- Total Income: Q1 FY27 ₹1,657.66 (Q4 FY26: ₹1,377.94, Q1 FY26: ₹1,460.32)
- Cost of materials consumed: Q1 FY27 ₹1,187.51 (Q4 FY26: ₹913.04, Q1 FY26: ₹995.64)
- Employee benefits expense: Q1 FY27 ₹81.33 (Q4 FY26: ₹67.74, Q1 FY26: ₹65.81)
- Finance costs: Q1 FY27 ₹48.88 (Q4 FY26: ₹56.43, Q1 FY26: ₹67.65)
- Depreciation: Q1 FY27 ₹45.40 (Q4 FY26: ₹41.24, Q1 FY26: ₹40.63)
- Profit before tax: Q1 FY27 ₹148.29 (Q4 FY26: ₹66.32, Q1 FY26: ₹124.99)
- Tax expense: Q1 FY27 ₹41.05 (Q4 FY26: ₹19.30, Q1 FY26: ₹31.90)
- Profit after tax: Q1 FY27 ₹107.24 (Q4 FY26: ₹47.02, Q1 FY26: ₹93.09)
- Other Comprehensive Income: Q1 FY27 ₹47.69 (Q4 FY26: ₹(24.11), Q1 FY26: ₹28.09)
- Total Comprehensive Income: Q1 FY27 ₹154.93 (Q4 FY26: ₹22.91, Q1 FY26: ₹121.18)
Key Ratios (Standalone):
- Earnings per share (Basic): Q1 FY27 ₹2.73 (Q4 FY26: ₹1.20, Q1 FY26: ₹2.47)
- Earnings per share (Diluted): Q1 FY27 ₹2.73 (Q4 FY26: ₹1.20, Q1 FY26: ₹2.46)
- Debt-Equity Ratio: 0.70 (Q4 FY26: 0.62, Q1 FY26: 0.83)
- Current Ratio: 0.78 (Q4 FY26: 0.94, Q1 FY26: 0.86)
- Operating Margin: 13.20% (Q4 FY26: 9.89%, Q1 FY26: 14.54%)
- Net Worth: ₹3,799.07 crores (Q4 FY26: ₹3,692.15 crores, Q1 FY26: ₹3,328.53 crores)
Capital Structure
- Paid-up Equity Share Capital: ₹39.35 crores (face value ₹1 each)
- Other Equity: ₹4,011.84 crores
Debt Information
The company has issued 70,000 rated, listed, secured, redeemable, non-convertible debentures of face value ₹1,00,000 each:
- ₹105 crores repaid on January 29, 2025
- ₹105 crores repaid on January 29, 2026
- ₹490 crores outstanding as of June 30, 2026
Debenture holders include:
- DBS Bank Limited: ₹430.50 crores outstanding
- Reliance General Insurance Company Limited: ₹35 crores outstanding
- Aditya Birla Sun Life Mutual Fund: ₹10.50 crores outstanding
Debentures are secured by first ranking exclusive pledge over identified shares of Aquapharm Chemical Limited (subsidiary).
Commercial Paper Outstanding
As of June 30, 2026:
- Amount: ₹200 crores
- Issue Date: April 23, 2026
- Redemption Date: July 22, 2026
Warrant Conversion Details
The Preferential Issue Committee allotted 1,60,00,000 convertible warrants at ₹280 per warrant on May 7, 2024. During FY26, the company received balance consideration of ₹336 crores and converted warrants into 1,60,00,000 equity shares on November 3, 2025.
Dividend Declaration
Interim dividend declared at 450% (₹4.50 per equity share of ₹1 each) for FY2026-27 with record date of August 4, 2026.
Security Cover Certificate
The document includes a detailed security cover certificate showing:
- Exclusive security cover ratio for debentures
- Total assets value: ₹9,308.55 crores
- Property, Plant and Equipment: ₹2,292.50 crores
- Investments: ₹4,082.63 crores (including ₹2,280 crores in equity shares)
- Cash and cash equivalents: ₹1,437.16 crores